No full text
Article (Scientific journals)
The role of the inhibitors of interleukin-6 signal transduction SHP2 and SOCS3 for desensitization of interleukin-6 signalling
Fischer, P.; Lehmann, U.; Sobota, R. M. et al.
2004In Biochemical Journal, 378 (Pt 2), p. 449-60
Peer Reviewed verified by ORBi
 

Files


Full Text
No document available.

Send to



Details



Keywords :
Animals; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Protein Tyrosine Phosphatases; Protein-Tyrosine Kinases; RNA, Messenger; Receptors, Interleukin-6; Repressor Proteins; STAT3 Transcription Factor; Signal Transduction; Suppressor of Cytokine Signaling Proteins; Trans-Activators; Transcription Factors; Transcription, Genetic; Mice, Knockout; Mice; Antigens, CD; Carrier Proteins; Cell Line; Cytokine Receptor gp130; DNA-Binding Proteins; Down-Regulation; Humans; Interleukin-6; Intracellular Signaling Peptides and Proteins; Janus Kinase 1; Kinetics; Membrane Glycoproteins; Tyrosine
Abstract :
[en] The immediate early response of cells treated with IL-6 (interleukin-6) is the activation of the signal transducer and activator of transcription (STAT)3. The Src homology domain 2 (SH2)-containing protein tyrosine phosphatase SHP2 and the feedback inhibitor SOCS3 (suppressor of cytokine signalling) are potent inhibitors of IL-6 signal transduction. Impaired function of SOCS3 or SHP2 leads to enhanced and prolonged IL-6 signalling. The inhibitory function of both proteins depends on their recruitment to the tyrosine motif 759 within glycoprotein gp130. In contrast to inactivation, desensitization of signal transduction is regarded as impaired responsiveness due to prestimulation. Usually, after activation the sensing receptor becomes inactivated by modifications such as phosphorylation, internalization or degradation. We designed an experimental approach which allows discrimination between desensitization and inactivation of IL-6 signal transduction. We observed that pre-stimulation with IL-6 renders cells less sensitive to further stimulation with IL-6. After several hours, the cells become sensitive again. We show that not only signal transduction through previously activated receptors is affected by desensitization but signalling through receptors which were not targeted by the first stimulation was also attenuated ( trans -desensitization). Interestingly, in contrast to inhibition, desensitization does not depend on the presence of functional SHP2. Furthermore, cells lacking SOCS3 show constitutive STAT3 activation which is not affected by pre-stimulation with IL-6. All these observations suggest that desensitization and inhibition of signalling are mechanistically distinct.
Disciplines :
Biochemistry, biophysics & molecular biology
Identifiers :
UNILU:UL-ARTICLE-2008-710
Author, co-author :
Fischer, P.
Lehmann, U.
Sobota, R. M.
Schmitz, J.
Niemand, C.
Linnemann, S.
Haan, Serge ;  Rheinisch - Westfälische Technische Hochschule Aachen - RWTH > Institute for Biochemistry
Behrmann, Iris ;  University of Luxembourg > Faculty of Science, Technology and Communication (FSTC) > Life Science Research Unit
Yoshimura, A.
Johnston, J. A.
Müller-Newen, G.
Heinrich, P. C.
Schaper, F.
More authors (3 more) Less
External co-authors :
yes
Language :
English
Title :
The role of the inhibitors of interleukin-6 signal transduction SHP2 and SOCS3 for desensitization of interleukin-6 signalling
Publication date :
2004
Journal title :
Biochemical Journal
ISSN :
1470-8728
Publisher :
Portland Press, London, United Kingdom
Volume :
378
Issue :
Pt 2
Pages :
449-60
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBilu :
since 26 April 2013

Statistics


Number of views
82 (1 by Unilu)
Number of downloads
0 (0 by Unilu)

Scopus citations®
 
64
Scopus citations®
without self-citations
55
WoS citations
 
59

Bibliography


Similar publications



Contact ORBilu